Sign in

CIK 0001472012

  • Non-accelerated filer

Immunome Inc.

Sign in to watch
Ticker
IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770694340
Phone
+1 610-321-3700
Business address
18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Director bought 5,000 shares at $9.38 ($46,900)
  13. 4 Option exercise Chief Scientific Officer acquired 5,200 shares (option exercise)
  14. 4 Open-market buy Director bought 7,800 shares at $7.78 ($60,684)
  15. 4 Open-market buy President and CEO bought 137,100 shares at $7.29 ($999,459)
  16. 4 Open-market buy Director bought 7,000 shares at $8.21 ($57,470)
  17. 4 Open-market buy Chief Technology Officer bought 12,300 shares at $8.42 ($103,566)
  18. 4 Open-market buy President and CEO bought 150,000 shares at $7.75 ($1,162,500)
  19. 4 Open-market buy President and CEO bought 100,000 shares at an average $9.62 ($962,181)
  20. 4 Open-market buy Chief Medical Officer bought 15,805 shares at $9.48 ($149,800)

Page 3 of 10 · 187 filings